APACU vs CLRB
Comparison between StoneBridge Acquisition II Corp - Units (1 Ord Cls A & 1 Rts) (APACU, Company) and Cellectar Biosciences Inc (CLRB, Company).
APACU is from the Financial Services sector, while CLRB is from the Healthcare sector.
APACU vs CLRB - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
APACU vs CLRB - Historical Returns
Returns include dividend reinvestment.
APACU vs CLRB - Annual Returns (2005 - 2026)
Returns include dividend reinvestment.
| Year | APACU | CLRB |
|---|---|---|
| 2026 | +3.49% | -19.60% |
| 2025 | +0.70% | -69.73% |
| 2024 | N/A | -89.55% |
| 2023 | N/A | +69.94% |
| 2022 | N/A | -75.91% |
| 2021 | N/A | -67.92% |
| 2020 | N/A | -16.47% |
| 2019 | N/A | +42.41% |
| 2018 | N/A | -88.69% |
| 2017 | N/A | +7.03% |
| 2016 | N/A | -83.33% |
| 2015 | N/A | -75.98% |
| 2014 | N/A | -59.34% |
| 2013 | N/A | -50.00% |
| 2012 | N/A | +64.44% |
| 2011 | N/A | -92.81% |
| 2010 | N/A | -98.99% |
| 2009 | N/A | +440.43% |
| 2008 | N/A | -22.95% |
| 2007 | N/A | -33.33% |
| 2006 | N/A | -53.68% |
| 2005 | N/A | -26.01% |
APACU vs CLRB Drawdown Comparison
The maximum drawdown for APACU was -4.12%, occurring on Mar 11, 2026. This drawdown has not yet recovered.
The maximum drawdown for CLRB was -100.00%, occurring on Jun 12, 2026. This drawdown has not yet recovered.
The current APACU drawdown is -1.66%. The current CLRB drawdown is -100.00%.
| Rank | APACU | CLRB |
|---|---|---|
| #1 | -4.12% Feb 11, 2026 - Mar 11, 2026 | -100.00% Nov 30, 2005 - Jun 12, 2026 |
| #2 | -1.96% Nov 26, 2025 - Jan 29, 2026 | -15.64% Nov 11, 2005 - Nov 22, 2005 |
| #3 | -0.63% Jan 29, 2026 - Feb 11, 2026 | -8.06% Nov 28, 2005 - Nov 30, 2005 |
| #4 | -0.50% Oct 23, 2025 - Nov 6, 2025 | N/A |
| #5 | -0.50% Nov 6, 2025 - Nov 26, 2025 | N/A |
| #6 | -0.40% Oct 2, 2025 - Oct 16, 2025 | N/A |
Correlation
Correlation between APACU and CLRB is -0.65 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks